[1]
Pivatto JĂșnior, F., da Silva, A.L.F., Bezerra, I.V., Pires, L.M., Amon, L.C., Blaya, M.B. e Scheffel, R.S. 2015. Major bleeding risk assessment in atrial fibrillation patients taking vitamin K antagonists. Clinical and Biomedical Research. 35, 2 (jul. 2015).